A549 cells infected with SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
IRF3 | hg19_v2_chr19_-_50169064_50169132 | 0.30 | 5.6e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_+_948803 Show fit | 34.40 |
ENST00000379389.4
|
ISG15 ubiquitin-like modifier |
|
chr4_-_169239921 Show fit | 17.56 |
ENST00000514995.1
ENST00000393743.3 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 |
|
chr21_+_42792442 Show fit | 16.63 |
ENST00000398600.2
|
myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
|
chr11_-_615570 Show fit | 14.18 |
ENST00000525445.1
ENST00000348655.6 ENST00000397566.1 |
interferon regulatory factor 7 |
|
chr11_-_615942 Show fit | 13.66 |
ENST00000397562.3
ENST00000330243.5 ENST00000397570.1 ENST00000397574.2 |
interferon regulatory factor 7 |
|
chr10_+_91087651 Show fit | 13.31 |
ENST00000371818.4
|
interferon-induced protein with tetratricopeptide repeats 3 |
|
chr2_-_163175133 Show fit | 12.93 |
ENST00000421365.2
ENST00000263642.2 |
interferon induced with helicase C domain 1 |
|
chr10_+_91092241 Show fit | 11.34 |
ENST00000371811.4
|
interferon-induced protein with tetratricopeptide repeats 3 |
|
chr1_+_79115503 Show fit | 9.10 |
ENST00000370747.4
ENST00000438486.1 ENST00000545124.1 |
interferon-induced protein 44 |
|
chr3_-_122283079 Show fit | 9.00 |
ENST00000471785.1
ENST00000466126.1 |
poly (ADP-ribose) polymerase family, member 9 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 41.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
9.3 | 27.8 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
2.1 | 27.8 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
2.4 | 26.9 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
5.8 | 23.0 | GO:0034343 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
3.3 | 19.7 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.8 | 16.6 | GO:0003373 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.9 | 14.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
1.1 | 12.8 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
1.1 | 11.7 | GO:0018377 | protein myristoylation(GO:0018377) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 32.4 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.0 | 29.8 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 21.9 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 16.7 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 11.2 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 8.7 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 6.8 | GO:0005771 | multivesicular body(GO:0005771) |
1.0 | 6.2 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.2 | 4.7 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.2 | 2.2 | GO:0031906 | late endosome lumen(GO:0031906) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 42.7 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
2.6 | 34.4 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 27.6 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.9 | 26.9 | GO:0070403 | NAD+ binding(GO:0070403) |
2.0 | 24.5 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 16.6 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 10.0 | GO:0042393 | histone binding(GO:0042393) |
0.2 | 7.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.7 | 6.8 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.8 | 6.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 27.8 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 3.7 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 2.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 1.9 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 1.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 1.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 1.6 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 1.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 1.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 1.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 98.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
2.4 | 50.9 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 6.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 6.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 5.1 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 3.8 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 1.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 1.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 1.1 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.9 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |